RxSight Inc.

14.70
-0.03 (-0.17%)
At close: Apr 25, 2025, 12:47 PM

Company Description

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally.

It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.

The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery.

It primarily serves cataract doctors.

The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017.

RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

RxSight Inc.
RxSight Inc. logo
Country United States
IPO Date Jul 30, 2021
Industry Medical - Devices
Sector Healthcare
Employees 498
CEO Dr. Ronald M. Kurtz M.D.

Contact Details

Address:
100 Columbia
Aliso Viejo, California
United States
Website https://www.rxsight.com

Stock Details

Ticker Symbol RXST
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001111485
CUSIP Number 78349D107
ISIN Number US78349D1072
Employer ID 94-3268801
SIC Code 3851

Key Executives

Name Position
Dr. Ronald M. Kurtz M.D. Co-President, Chief Executive Officer & Director
Eric J. Weinberg Co-President & Chief Commercial Officer

Latest SEC Filings

Date Type Title
Apr 21, 2025 DEF 14A Filing
Apr 21, 2025 ARS/A [Amend] Filing
Apr 21, 2025 DEFA14A Filing
Apr 15, 2025 4 Filing
Apr 08, 2025 SCHEDULE 13G Filing
Apr 03, 2025 8-K Current Report
Mar 13, 2025 4 Filing
Feb 27, 2025 4 Filing
Feb 27, 2025 4 Filing
Feb 27, 2025 4 Filing